Yahoo Web Search

Search results

1. • 

     AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC...

     FOX 23 News Albany· 2 days ago

     Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C....

2. • Update on the STING signaling pathway in developing nonalcoholic fatty liver disease

     Medical Xpress· 3 days ago

     Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver condition worldwide, affecting about 25% of the global population due to the increasing ...

3. • Akero Therapeutics, Inc. (AKRO) Investors: June 25, 2024 Filing Deadline in Securities Class Action...

     Morningstar· 4 days ago

     The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern ...

4. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 4 days ago

     SAN FRANCISCO, May 23, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to submit their losses now. Class Period: Sep. 13, 2022 – Oct. 9, 2023Lead Plaintiff Deadline

5. • 

     Is Madrigal Pharmaceuticals Stock a Buy?

     Motley Fool via Yahoo Finance· 6 days ago

     It is caused by a dangerous buildup of fat in the liver that causes damage and scarring (also known as fibrosis). People who suffer from obesity and type...

6. • 

     Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ... By...

     Investing.com· 3 days ago

     The transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 5,500...

7. • How air pollution affects the digestive system

     Medical Xpress· 3 days ago

     This recent research has been focused on how PM2.5 exposure triggers stress responses within the digestive system's cells. When PM2.5 disrupts these organelles, it creates a chain reaction within ...

8. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 2 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Equinix (NASDAQ: EQIX) ...

9. • Galectin Therapeutics (NASDAQ:GALT) Stock Price Passes Above Two Hundred Day Moving Average of $2.25

     ETF DAILY NEWS· 6 days ago

     Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.25 and ...

10. • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 6 days ago

      Engitix Ltd (‘Engitix’), a biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, ...